Skip to main content
. 2019 Oct 21;25(39):6025–6040. doi: 10.3748/wjg.v25.i39.6025

Figure 4.

Figure 4

Total remission rates of peptic ulcers between allicin and control groups (intent-to-treat/per-protocol analysis). The total remission rate across allicin groups was significantly higher than that of the control group for ITT/PP analyses [95.99% (359/374) vs 89.25% (332/372), odds ratio = 3.13, 95% confidence interval: 1.51-6.51, P = 0.004]. CI: Confidence interval.